Palvella Therapeutics, Inc.
Nasdaq · Healthcare · Pharmaceutical Preparations · Wayne, PA
PVLA chart
What traders are saying about $PVLA
Latest postsPalvella Therapeutics, Inc. news
- Palvella Therapeutics, Inc. (PVLA) Stock Price, News, Quote & History
Yahoo! Finance Canada ·
- Palvella Therapeutics Eyes QTORIN Launch as Rare-Disease Pipeline Expands
marketbeat.com ·
- What Does Palvella Therapeutics (PVLA) NDA Progress Mean After Its Phase 3 Data?
Yahoo Finance ·
- Palvella Therapeutics (PVLA) Could Be 45% Undervalued Following Fresh QTORIN Updates
Simply Wall Street ·
- Palvella Therapeutics, Inc. Estimates – NASDAQ:PVLA
TradingView ·
- Palvella Therapeutics COO Kathleen Goin Executes Full Stock Option Exercise and Sells All Shares Under 10b5-1 Plan
Kalkine Media ·
- Ligand to Host Investor Day on December 8, 2026
Yahoo Finance ·
- Form 144 PALVELLA THERAPEUTICS For: 21 October By Investing.com
Investing.com Canada ·
- William Blair Expands Biotech Research as Veteran Analyst Alethia Young Initiates Coverage
Yahoo Finance ·
- Analysts Are Bullish on Top Healthcare Stocks: Ocular Therapeutix (OCUL), Palvella Therapeutics (PVLA)
The Globe and Mail ·
- Palvella Therapeutics to Present Phase 3 SELVA and Phase 2 TOIVA Results, Along With New Pediatric Analyses, at 2026 PeDRA Annual Conference
Yahoo Finance ·
- Palvella Therapeutics to Participate in the Chardan 10th Annual Healthcare Conference
Yahoo Finance ·
Palvella Therapeutics, Inc. key financials
| USD | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Revenue | – | – | $42.8M | $25.9M |
| Net income | -$41.7M | -$17.4M | $18.7M | -$33.3M |
| Diluted EPS | $-3.71 | $-7.83 | $2.17 | – |
| Total assets (year end) | $59.6M | $88.2M | $7.5M | $95.5M |
| Cash and equivalents (year end) | $58.0M | $83.6M | $7.3M | $38.6M |
Calendar-year figures as reported to the SEC in XBRL filings.
Recent SEC filings
About Palvella Therapeutics, Inc.
- Ticker
- PVLA (Nasdaq)
- Industry
- Pharmaceutical Preparations
- Headquarters
- Wayne, PA
- Incorporated in
- NV
- Fiscal year end
- December 31
- SEC CIK
- 1583648
- Former names
- PIERIS PHARMACEUTICALS, INC., Marika Inc.
Frequently asked questions
What exchange is Palvella Therapeutics, Inc. listed on?
Palvella Therapeutics, Inc. trades on the Nasdaq under the ticker symbol PVLA.
What industry is Palvella Therapeutics, Inc. in?
Palvella Therapeutics, Inc. is classified by the SEC under "Pharmaceutical Preparations", part of the Healthcare sector on StockTweeting.
Where is Palvella Therapeutics, Inc. headquartered?
Palvella Therapeutics, Inc.'s business address on file with the SEC is in Wayne, PA.
When does Palvella Therapeutics, Inc.'s fiscal year end?
Palvella Therapeutics, Inc.'s fiscal year ends on December 31.
How much revenue did Palvella Therapeutics, Inc. report?
Palvella Therapeutics, Inc. reported $42.8M in revenue for calendar year 2023, according to its SEC filings.